World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
47342
World Ranking
5538
National Ranking
2988

Overview

Gary S. Sachs is affiliated with Harvard University in the United States. Their research primarily falls within the field of Medicine, with a particular focus on Psychiatry and Mental Health. Additional subfields include Neurology, Geriatrics and Gerontology, Pharmacology, and Biological Psychiatry.

The scientist's work spans several main topics related to mental health and neurological conditions, including:

  • Bipolar Disorder and Treatment
  • Schizophrenia Research and Treatment
  • Electroconvulsive Therapy Studies
  • Neurological Disorders and Treatments
  • Pharmaceutical Practices and Patient Outcomes
  • Treatment of Major Depression
  • Tryptophan and Brain Disorders

Gary S. Sachs has published extensively, with significant contributions to the following venues:

  • Psychopharmacology Bulletin
  • Journal of Psychopharmacology
  • The Journal of Clinical Psychiatry
  • European Psychiatry

Selected recent papers authored or co-authored by Gary S. Sachs include:

  • "Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening," 2025, Psychopharmacology Bulletin
  • "Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania," 2021, Journal of Psychopharmacology
  • "Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice," 2025, Psychopharmacology Bulletin
  • "Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing," 2025, Psychopharmacology Bulletin
  • "Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide," 2025, Psychopharmacology Bulletin

The scientist frequently collaborates with several colleagues, including:

  • Michael E. Thase
  • Alisa B. Busch
  • Richard G. Frank
  • Mark S. Bauer
  • Stephen R. Wisniewski

Best Publications

  • Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

    Robert M.A. Hirschfeld;Janet B.W. Williams;Robert L. Spitzer;Joseph R. Calabrese

  • Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

    Manuel A R Ferreira;Michael C O'Donovan;Yan A Meng;Ian R Jones

  • A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

    Joseph R. Calabrese;Charles L. Bowden;Gary S. Sachs;John A. Ascher

  • Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  • Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell

  • Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Roy H Perlis;Sachiko Miyahara;Lauren B Marangell;Stephen R Wisniewski

  • A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder

    Charles L. Bowden;Joseph R. Calabrese;Gary Sachs;Lakshmi N. Yatham

  • Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Roy H. Perlis;Michael J. Ostacher;Jayendra K. Patel;Lauren B. Marangell

  • A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder

    Joseph R. Calabrese;Charles L. Bowden;Gary Sachs;Lakshmi N. Yatham

  • Whole-genome association study of bipolar disorder

    P Sklar;J W Smoller;J Fan;J Fan;M A R Ferreira

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Naomi M Simon;Michael W Otto;Stephen R Wisniewski;Mark Fossey

  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

    Alan S. Bellack;Charles L. Bowden;Christopher R. Bowie;Matthew J. Byerly

  • A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder

    Joseph R. Calabrese;Trisha Suppes;Charles L. Bowden;Gary S. Sachs

  • Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

    David J. Miklowitz;Michael W. Otto;Ellen Frank;Noreen A. Reilly-Harrington

  • Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

    S.Nassir Ghaemi;Gary S Sachs;Alice M. Chiou;Ananda K Pandurangi

  • Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

    Charles B. Nemeroff;Dwight L. Evans;Laszlo Gyulai;Gary S. Sachs

  • Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety

    Gary S. Sachs;Fred Grossman;S. Nassir Ghaemi;Akiko Okamoto

Frequent Co-Authors

Michael E. Thase
Michael E. Thase University of Pennsylvania
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University
David J. Miklowitz
David J. Miklowitz University of California, Los Angeles
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Roy H. Perlis
Roy H. Perlis Harvard University
Jerrold F. Rosenbaum
Jerrold F. Rosenbaum Harvard University
Terence A. Ketter
Terence A. Ketter Stanford University
Stephen R. Wisniewski
Stephen R. Wisniewski University of Pittsburgh
Mark H. Pollack
Mark H. Pollack Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open up new career pathways, whether you’re aiming to work in clinical care or healthcare administration. Many students who consider studying Medicine in the USA are also interested in related advanced nursing and management programs. For those seeking a rapid transition into specialized mental health fields, shortest post master's pmhnp online programs offer a fast track to becoming a Psychiatric Mental Health Nurse Practitioner.

Cost is a key concern when pursuing higher education. If you are considering a leadership or administrative career, finding a program that fits your budget is crucial. Learn more about healthcare administration degree cost and explore your options for affordable, reputable training. Those looking for graduate degrees in administration should review some of the most cheap mha programs available online.

Advanced practitioners and future leaders may also benefit from exploring cheap dnp online programs—a smart choice for those aiming for the highest levels in clinical nursing practice without incurring excessive debt. Carefully comparing program costs, flexibility, and accreditation will help you find the best fit for your goals.

Best Scientists Citing Gary S. Sachs

Trending Scientists